Sign in
4

Changes in Ownership

CRISPR Therapeutics AG Filed Acc 0001193125-26-396944

Director sold 13,679 shares at $57.09 ($780,935)

  • Director acquired 30,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Behbahani Ali · Director

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2026-09-17 Exercise or conversion : show line 1 in the form +30,000 $14.00 $420,000 30,316 D
2026-09-17 Sale : show line 2 in the form −13,679 $57.09 $780,935 16,637 D
Open-market sales · 13,679 sh · avg $57.09 · $780,935

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2026-09-17 Exercise or conversion : show line 3 in the form Stock Option (Right to Buy) −30,000 0 D
Loading xslF345X06/ownership.xml…